Amgen Inc. (AMGN) Q1 2021 Earnings Results

Amgen Misses on EPS, Stock Down 0.15%

Amgen's earnings report shows a slight miss on EPS, which may raise concerns among investors about the company's short-term performance. The stock reacted with a minor decline of 0.15%, indicating a muted response from the market. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.70	N/A	-7.57%

Management

Management commentary

Tone: Defensive

Overall, management expressed caution regarding current market conditions. They highlighted the importance of maintaining a steady course amid uncertainties.

Management acknowledged the challenges faced during the quarter.

They emphasized a focus on long-term growth despite short-term hurdles.

Amgen Misses on EPS, Stock Down 0.15%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Misses on EPS, Stock Down 0.15%

Key numbers

Management commentary